Search Within

Archie Tse

Formats
  1. Meeting Abstract (18)
  2. Journal Article (16)
Groups
  1. Department of Medicine (17)
  2. Solid Tumor Oncology Division (17)
  3. Center for Pancreatic Cancer Research (13)
  4. Gastrointestinal Oncology Service (12)
  5. Biostatistics Service (10)
  6. Body Imaging Service (10)

More Groups

People
  1. Gary Schwartz (31)
  2. Manish Shah (13)
  3. David Kelsen (9)
  4. Richard Carvajal (9)
  5. Robert Lefkowitz (7)
  6. Eileen O'Reilly (6)

More People

Years
  1. 2010 (3)
  2. 2009 (8)
  3. 2008 (4)
  4. 2007 (5)
  5. 2006 (3)
  6. 2005 (4)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (6)
  3. Clinical Cancer Research (5)
  4. Cancer Chemotherapy and Pharmacology (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. American Society of Clinical Oncology (12)
  3. Springer (2)
  4. Karger (1)
  5. Oxford University Press (1)
  6. Pergamon-Elsevier Science Ltd (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I clinical trial of gemcitabine (GEM) in combination with PF-00477736 (PF-736), a selective inhibitor of CHK1 kinase
    Meeting Abstract

    Brega, N.; McArthur, G. A.; Britten, C.; Wong, S. G.; Wang, E.; Wilner, K. D.; Blasina, A.; Schwartz, G. K.; Gallo, J.; Tse, A. N.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase
    Journal Article

    McNeely, S.; Conti, C.; Sheikh, T.; Patel, H.; Zabludoff, S.; Pommier, Y.; Schwartz, G.; Tse, A.
    Cell Cycle (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial
    Meeting Abstract

    Kelsen, D.; Jhawer, M.; Ilson, D.; Tse, A.; Randazzo, J.; Robinson, E.; Capanu, M.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Chk1 inhibition after replicative stress causes a double strand break response mediated primarily by DNA-dependent protein kinase
    Meeting Abstract

    McNeely, S. C.; Conti, C.; Sheikh, T.; Pommier, Y.; Schwartz, G. K.; Tse, A. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies
    Journal Article

    Tse, A. N.; Wu, N.; Patel, D.; Haviland, D.; Kemeny, N.
    Cancer Chemotherapy and Pharmacology (2009)

    Fulltext@MSK | Save
  • 90-kDa heat shock protein inhibition abrogates the topoisomerase i poison-induced G(2)/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1
    Journal Article

    Tse, A. N.; Sheikh, T. N.; Ho, A.; Chou, T. C.; Schwartz, G. K.
    Molecular Pharmacology (2009)

    Fulltext@MSK | Save
  • Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780
    Journal Article

    Nair, J. S.; Ho, A. L.; Tse, A. N.; Coward, J.; Cheema, H.; Ambrosini, G.; Keen, N.; Schwartz, G. K.
    Molecular Biology of the Cell (2009)

    Fulltext@MSK | Save
  • Regional chemotherapy for unresectable primary liver cancer: Results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
    Journal Article

    Jarnagin, W. R.; Schwartz, L. H.; Gultekin, D. H.; Gonen, M.; Haviland, D.; Shia, J.; D'Angelica, M.; Fong, Y.; DeMatteo, R.; Tse, A.; more...
    Annals of Oncology (2009)

    Fulltext@MSK | Save